Botanical extracts of Echinacea purpurea have been widely used for the treatment of upper respiratory infections. We sought to chemically examine fungal endophytes inhabiting E. purpurea, and to identify compounds produced by these endophytes with in vitro cytokine-suppressive activity. Twelve isolates from surface sterilized seeds of E. purpurea were subjected to fractionation and major components were isolated. Sixteen secondary metabolites belonging to different structural classes were identified from these isolates based on NMR and mass spectrometry data. The compounds were tested for their influence on cytokine secretion by murine macrophage-type cells. Alternariol (1), O-prenylporriolide (4), porritoxin (10) β-zearalenol (13), and (S)-zearalenone (14) inhibited production of TNF-α from RAW 264.7 macrophages stimulated with LPS in the absence of any significant cytotoxicity. This is the first report of a cytokine-suppressive effect for 4. The results of this study are particularly interesting given that they show the presence of compounds with cytokinesuppressive activity in endophytes from a botanical used to treat inflammation. Future investigations into the role of fungal endophytes in the biological activity of E. purpurea dietary supplements may be warranted.
Medicinal plants retain their popularity as an important part of health care worldwide. The Echinacea genus has been employed for treating rhinosinusitis, the common cold, upper respiratory infections, and other inflammatory conditions [1] [2] [3] [4] . While debates over therapeutic effects of Echinacea abound in the literature, preparations of this multi-million dollar herb consistently rank among the best-selling botanicals in the United States [5] , and are also very popular in Europe [6] . Some clinical studies have shown faster recovery from cold episodes on consumption of Echinacea preparations, while others suggest no useful impact [3] .
The purported health benefits of Echinacea preparations are generally believed to occur via action on the immune system. In support of this, a number of in vitro studies have shown various immunomodulatory effects of Echinacea (reviewed in [7] ). However, these studies have also shown confounding and often conflicting results. Echinacea extracts contain an array of different chemical constituents, including alkylamides, phenylpropanoids, polysaccharides, and volatile oils [3] , which have different biological effects. Moreover, the levels of these constituents in a particular Echinacea product can vary depending on the species, plant parts, and/or geographical origin of plants used, and the method of processing [3] . Such variability may be one explanation for the inconsistencies reported for both clinical and in vitro studies of Echinacea preparations. Furthermore, the scientific community that studies botanical medicines has become increasingly aware of the potential importance of endophytes (microbes that reside in internal living tissues of plants) in altering or influencing the chemical composition of botanicals. Endophytes live in close association with plants, and their populations can differ depending on seasonal changes and geographic conditions [8, 9] . Hence, it has been proposed that the biological activity of a particular botanical could vary due to differences in endophyte profile. Along these lines, there is evidence that bacterial endophytes can alter the in vitro immunomodulatory activity of Echinacea and other botanicals [10, 11] , and it has been shown that several bacterial endophytes from Echinacea possess immunomodulatory activity [12] . Several recent studies have demonstrated that Echinacea plants also harbor fungal endophytes [13, 14] .
However, the potential immunomodulatory effects of these fungal endophytes or their constituents have yet to be evaluated. Our goals with this project were to culture and characterize fungal endophytes from E. purpurea seeds, isolate secondary metabolites from these endophytes, and evaluate their activity in vitro against RAW 264.7 murine macrophage-type cells. Our study focused on fungal endophytes isolated from Echinacea purpurea (L.) Moench (Asteraceae), which is the species most commonly cultivated for medicinal use in the United States. Table 1 : Fungal endophytes isolated from surface sterilized Echinacea purpurea seed tissues. Twelve different isolates belonging to seven different operational taxonomic units (OTUs) were investigated in this study. The ITS region was sequenced and used for identification with GenBank BLAST search. All sequences are deposited at GenBank (accession numbers below). The strain numbers are internal references to the fungal library at the University of North Carolina at Greensboro.
Strains
Fungal taxon GenBank accession number G327
Epicoccum nigrum
Twelve fungal isolates from surface sterilized seeds of E. purpurea (Table 1) were subjected to isolation. From these, 16 known fungal Porritoxin [37] G330 11 11 11 11 Equisetin [38] G328 G330 G335 G389 12 12 5'-Epi-equisetin [39] G330
Orevactaene [42] G327 G390 G391 G393 secondary metabolites ( Table 2 and Figure 1 ) were identified. These compounds were identified by comparison of their NMR and mass spectrometry data with literature (Table S1 ).
The 16 compounds (Table 2) were tested for cytotoxicity against RAW 264.7 cells using rhodamine 123, a dye that is retained by cells with intact mitochondria and lost by cells undergoing either apoptosis or necrosis [15] . A range of concentrations was tested, from 0.0025-25 µg/mL, although effects were only noted at 2.5 and 25 µg/mL ( Figure 2A ). (S)-10, 11-Dehydrocurvularin (8) and 8-Omethyl-fusarubin (15) caused substantial dose-dependent cell death, while lower but significant levels of cytotoxicity were observed with porritoxin (10), equisetin (11) and 5'-epi-equisetin (12) . Two of the resorcylic acid lactones, β-zearalenol (13) and (S)zearalenone (14), have been reported to be cytotoxic towards RAW 264.7 cells [16, 17] . Although we did not observe this, it is possible that cytotoxicity could be observed at higher doses or longer incubation times.
The isolated fungal metabolites (Table 2) were also tested at the same range of concentrations for their ability to affect both constitutive and LPS-induced production of TNF-α. Levels of constitutive TNF-α production from RAW 264.7 cells were low (50-100 pg/mL), and none of the compounds caused statistically significant enhancement or suppression ( Figure S1 ). In contrast, in the presence of 10 ng/mL LPS, production of TNF-α was robust, with 6-8 ng accumulating in cultures in the different experiments. For purposes of comparison, these data are shown as percent of control ( Figure 2B ). Several compounds, 1, 4, 13, and 14 , demonstrated pronounced inhibition of LPS-induced TNF-α production in the absence of significant toxicity. Compounds 4 and 9 are structurally related, but compound 4 was a more potent inhibitor of TNF-α production. This observation suggests that the diol moiety in 9 decreases potency. Compound 10 produced a weak cytotoxic effect and strongly inhibited LPS-induced production of TNF-α, while compounds 11 and 12 also produced weak cytotoxic effects but enhanced TNF-α production for LPS treated cells ( Figure 2B ). It is possible that these compounds produce an effect akin to activation-induced apoptosis, first acting in concert with LPS to activate the cells, which is followed by an apoptotic response [18] . Whereas studies on fungal endophytes present in other plant organs exist [13, 19] , this is the first to investigate endophytes present in E. purpurea seeds. The rationale is that fungi present in seed material may be transmitted vertically (from parent to progeny) and may be host-specific. However, it is also possible to find horizontally transmitted endophytes (originating from the environment) in seeds.
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Thus, the investigated fungi may be in therapeutic preparations, however, it is more common to employ root material for dietary supplements from this botanical [20] . Future studies of endophytes from other E. purpurea plant tissues might be of interest.
It is notable that Echinacea purpurea preparations are commonly used to treat inflammation, and the cytokine-suppressive activity observed for the fungal metabolites is consistent with an antiinflammatory effect. Moreover, it is possible that the toxicity of several mycotoxins encountered in this study could influence the therapeutic properties of herbal preparations. However, the studied metabolites were produced by cultured endophytes. Whether they are present at biologically relevant concentrations to alter the toxicity or biological activity of Echinacea preparations is a question that would require further investigation.
In summary, a number of compounds with in vitro cytokinesuppressive activity were isolated from the fungal endophytes of E. purpurea seeds. Although no new compounds were encountered, this is the first report of cytokine suppression by compound 4. [21] and placed on 1.5 % water agar Petri dishes. All fungi were isolated within 14 days of culture and three times single spore isolated to obtain pure cultures.
Experimental

General Instrumentation Techniques
Endophyte Identification: Axenic cultures were harvested and ground under sterile conditions using liquid nitrogen. DNA amplification was performed combining the primers ITS1F/ITS1 and ITS4 [22, 23] under defined cycling conditions [24] . PCR products were purified with a QIAquick Purification Kit (QIAGEN Inc., Valencia, CA, USA) and sequenced (Eurofins MWG Operon LLC, Huntsville, AL, USA). The sequences were manually edited and identified by BLASTn search against authentic sequences in GenBank. Sequences from the entire ITS region (IT1-5.8-ITS2) were deposited at GenBank (Table 1) .
Extraction and Isolation of Fungal Secondary Metabolites:
Methods for preparing fungal inoculum for growth on rice, and procedures for isolation of secondary metabolites, have been detailed [24] . Key references for the characterization of all 16 compounds are provided as Supporting Information (Table 1S) .
Cytotoxicity Assays and Measurement of TNF-α:
Each compound was tested in duplicate experiments, performed on different days, over a range of concentrations (0.0025-25.0 µg/mL), with two biological replicates in each experiment (for a total of four biological replicates). Ethanol (1% final concentration) was used as the diluent for all but three compounds (1, 2, and 15) where dimethylsulfoxide (DMSO) was used (0.2% final concentration). The compounds were tested for toxicity using the rhodamine 123 (Rho123) assay. Cells were treated overnight with each secondary metabolite in 96 well plates. After incubation, the supernatant was removed, and Rho123 was added in the buffer for 30 min (5 µM final concentration), removed, and cells washed with 1X PBS [28] . The fluorescence was measured using a BMG FLUOstar Galaxy microplate reader (492/538) (BMG LABTECH GmbH, Ortenberg, Germany). For TNF-α testing, cells were treated, supernatants harvested, and then TNF-α measured using murine TNF-α ELISA kit purchased from eBioscience, Inc. (San Diego, CA). To stimulate TNF-α production, 10 ng/mL ultrapure LPS from Salmonella minnesota R595 (List Biological Laboratories, Inc. Campbell, CA, USA) was used. As a positive control for inhibition of TNF-α production, the compound dodeca-2E,4E-dienoic acid isobutylamide (ChromaDex, Irvine, CA, USA) was used at a concentration of 25 µg/mL. The cytokine-suppressive activity of this compound has been documented elsewhere [29] .
Statistical Analysis:
Experimental results were analyzed with a one way ANOVA with Tukey's post hoc test using Prism software (GraphPad Software, Inc., La Jolla, CA, USA).
Supplementary data:
Structures of isolated compounds, highresolution MS data, and effects of extracts on constitutive production of TNF-α are included as supplementary data.
